RxDoctor Payments Data

Omar Arnaout, MD

Neurological Surgery · Boston, MANPI 1528379641

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,205 of the $4,780 with a category attached, or 88.0%. 4 manufacturers reported payments, led by Servier Pharmaceuticals LLC at 58.3% of the total.

$4,780in general payments, 2019–2025

Across 6 payments — averaging $796.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$3K
  • Pramand LLC$2K
  • BK Medical Holding Company Inc.$400
  • Johnson & Johnson$17
$96,834in research payments, 2019–2025

Across 17 payments — averaging $5696.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pramand LLC$97K

What the payments were for

  • Consulting fees$4,20588%
  • Food & beverage$57512%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Servier Pharmaceuticals LLC2$2,788
Pramand LLC2$1,575
BK Medical Holding Company Inc.1$400
Johnson & Johnson1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,780 in reported general payments places this provider in the 55th percentile of 183 neurological surgery providers in Massachusetts.

See all neurological surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$179,852
Medicare patients
177
Services billed
340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →